HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and The... HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies. 詳細を表示
New Leadership Appointments; Positive Clinical and Regulatory Reports for the Lead Product Candidate, HB-200 (eseba-vec); On track to initiate the Phase 2/3 “AVALON-1” study with eseba-vec in Q4...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.165 | -8.00970873786 | 2.06 | 2.18 | 1.895 | 68487 | 2.06033431 | CS |
4 | -0.505 | -21.0416666667 | 2.4 | 2.6003 | 1.88 | 60287 | 2.27751079 | CS |
12 | -2.345 | -55.3066037736 | 4.24 | 4.32 | 1.88 | 55476 | 2.95108754 | CS |
26 | -4.555 | -70.6201550388 | 6.45 | 6.783 | 1.88 | 83521 | 4.80568168 | CS |
52 | -5.115 | -72.967189729 | 7.01 | 10.5 | 1.88 | 424100 | 7.55609598 | CS |
156 | -23.205 | -92.4501992032 | 25.1 | 30.5 | 1.88 | 1206593 | 15.32678487 | CS |
260 | -122.205 | -98.4730056406 | 124.1 | 200 | 1.88 | 787282 | 22.42379982 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約